Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer

Cancer Letters

Volumn 244, Issue 2, 2006, Pages 203-210

  Jang, Ki Seok ^a   Han, Hong Xiu ^a   Paik, Seung Sam ^a   Brown, Powel H ^b   Kong, Gu ^a  

^a Hanyang University   (South Korea)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Breast cancer; Estrogen receptor; Id 1; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; INHIBITOR OF DEOXYRIBONUCLEIC ACID BINDING; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CYTOPATHOLOGY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LYMPH NODES; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33749251816     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.12.016     Document Type: Article

References (33)

1. Benezra R., Davis R.L., Lockshon D., Turner D.L., and Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61 (1990) 49-59
2. Lassar A.B., Skapek S.X., and Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6 (1994) 788-794
3. Benezra R. The Id proteins: targets for inhibiting tumor cells and their blood supply. Biochim. Biophys. Acta 1551 (2001) F39-F47
4. Ruzinova M.B., and Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13 (2003) 410-418
5. Benezra R. Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc. Med. 11 (2001) 237-241
6. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401 (1999) 670-677
7. Norton J.D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 22 Pt 22 (2000) 3897-3905
8. Jang T.J., Jung K.H., and Choi E.A. Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer. Int. J. Cancer (2005)
9. Matsuda Y., Yamagiwa S., Takamura M., Honda Y., Ishimoto Y., Ichida T., et al. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 104 (2005) 1037-1044
10. Israel M.A., Hernandez M.C., Florio M., Andres-Baqui P.J., Mantani A., Carter J.H., et al. Id gene expression as a key mediator of tumor cell biology. Cancer Res. 59 (1999) 1726s-1730s
11. Maruyama H., Kleeff J., Wildi S., Friess H., Buchlar M.W., Israel M.A., et al. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am. J. Pathol. 155 (1999) 815-822
12. Kebebew E., Treseler P.A., Duh Q.Y., and Clark O.H. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer. Surgery 128 (2000) 952-957
13. Langlands K., Down G.A., and Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res. 60 (2000) 5929-5933
14. Lin C.Q., Singh J., Murata K., Itahana Y., Parrinello S., Liana S.H., et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 60 (2000) 1332-1340
15. Takai N., Miyazaki T., Fujisawa K., Nasu K., and Miyakawa I. Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. Cancer Lett. 165 (2001) 185-193
16. Lee K.T., Lee Y.W., Lee J.K., Choi S.H., Rhee J.C., Paik S.S., et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. Br. J. Cancer 90 (2004) 1198-1203
17. Nishimine M., Nakamura M., Mishima K., Kishi M., Kirita T., Sugimura M., et al. Id proteins are overexpressed in human oral squamous cell carcinomas. J. Oral. Pathol. Med. 32 (2003) 350-357
18. Kebebew E., Treseler P.A., Duh Q.Y., and Clark O.H. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer. Surgery 134 (2003) 235-241
19. Schindl M., Schoppmann S.F., Strobel T., Heinzl H., Leisser C., Horuat R., et al. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin. Cancer Res. 9 (2003) 779-785
20. Schindl M., Oberhuber G., Obermair A., Schoppmann S.F., Karner B., and Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 61 (2001) 5703-5706
21. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., and Wong Y.C. Over expression of ID-1 in prostate cancer. J. Urol. 167 (2002) 2598-2602
22. Coppe J.P., Itahana Y., Moore D.H., Bennington J.L., and Desprez P.Y. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin. Cancer Res. 10 (2004) 2044-2051
23. Fong S., Itahana Y., Sumida T., Singh J., Coppe J.P., Lio Y., et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl Acad. Sci. USA 100 (2003) 13543-13548
24. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
25. Fong S., Debs R.J., and Desprez P.Y. Id genes and proteins as promising targets in cancer therapy. Trends Mol. Med. 10 (2004) 387-392
26. Yokota Y., and Mori S. Role of Id family proteins in growth control. J. Cell Physiol. 190 (2002) 21-28
27. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horuat R., et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104 (2003) 677-682
28. Dorai H., and Sampath T.K. Sampath bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J. Bone Joint Surg. Am. 83-A Suppl. 1 (2001) S70-S78
29. Hansen S., Grabau D.A., Rose C., Bak M., and Sorensen F.B. Sorensen angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab. Invest. 78 (1998) 1563-1573
30. Singh J., Murata K., Itahana Y., and Desprez P.Y. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21 (2002) 1812-1822
31. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., and Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell Biol. 18 (1998) 4577-4588
32. Lyden D., Hattori K., Dias S., Costa C., blaikie P., Butros L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
33. Uzzan B., Nicolas P., Cucherat M., and Perret G.Y. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 64 (2004) 2941-2955